Breast cancer: Should we assess HER2 status by Oncotype DX?

Nat Rev Clin Oncol. 2011 Dec 6;9(1):12-4. doi: 10.1038/nrclinonc.2011.188.
No abstract available

Publication types

  • News

MeSH terms

  • Biological Assay / instrumentation*
  • Biomarkers, Tumor
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • Female
  • Genes, erbB-2 / genetics*
  • Humans
  • In Situ Hybridization, Fluorescence / instrumentation
  • In Situ Hybridization, Fluorescence / methods
  • Prognosis
  • Receptor, ErbB-2 / genetics*

Substances

  • Biomarkers, Tumor
  • Receptor, ErbB-2